Skip to main content
Caplight Logo









Lenoss Medical

Lenoss Medical

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://lenoss.com/

Last Round

Accelerator

Jun 2, 2026

Total Funding Raised

$5.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lenoss Medical is a medical device company that has developed the OsteoPearl VBA System, a biologic, cement-free technology for treating vertebral compression fractures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biological allograftvertebral compression fractureskyphoplasty alternativebone graftspine surgeryminimally invasive surgerybone healingmedical devicebiologicscement-free implantorthobiologicsspine implantinterventional radiologyosteoporosis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lenoss Medical Comparables

Compare Lenoss Medical with similar companies based on industry and business-model similarity.

Lenoss Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Life Spine, Inc.
73%
Medtronic
73%
Globus Medical
72%

Lenoss Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 2, 2026
VC RoundMar 17, 2026
GrantSep 17, 2025
Series AMay 9, 2024
SeedMay 5, 2021

Key People

Founding team and executive leadership

Dom Messerli

President & CEO

Executive Team

Lenoss Medical Investors

Notable investors and investment history

Lenoss Medical investors
InvestorRounds
Rouge VenturesSeries A
Vodia CapitalSeries A
Cherrystone Angel GroupSeries A, Seed
MedTech InnovatorAccelerator
Magpie MedTech VenturesSeed, VC Round
Beacon AngelsSeed, VC Round
Rhode Island Life Science HubGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Grew 27% QoQ from 11 to 14 employees

  • Jun 2, 2026

    Received funding from MedTech Innovator.

Lenoss Medical Filings

Explore SEC and related filing metadata, where available.

Lenoss Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lenoss Medical's valuation, stock price, and market status.

Is Lenoss Medical a public or private company?

Lenoss Medical is a private company.

What is the current stock price of Lenoss Medical?

Lenoss Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Lenoss Medical worth (valuation)?

Valuation information for Lenoss Medical is not publicly available.

Can I buy Lenoss Medical stock?

Lenoss Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lenoss Medical's last funding round?

Lenoss Medical's most recent funding round was Debt on March 17, 2026.

Who are the main investors in Lenoss Medical?

Key investors in Lenoss Medical include Xcellerant Ventures.

Will Lenoss Medical IPO soon?

No public IPO plans have been announced for Lenoss Medical.

How can I track Lenoss Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lenoss Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersProvidence, Rhode Island
Employee Range14
Year Founded2017
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?